These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21192131)

  • 1. [Clinical manifestations of antiphospholipid syndrome].
    Alba P; Astesana P; Babini A; Yorio M
    Rev Fac Cien Med Univ Nac Cordoba; 2010; 67(1):40-9. PubMed ID: 21192131
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated cerebral sinovenous thrombosis: a rare case of neonatal antiphospholipid syndrome.
    De Carolis MP; Salvi S; Bersani I; De Carolis S
    Indian Pediatr; 2012 May; 49(5):411-2. PubMed ID: 22700668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric acid levels in primary antiphospholipid syndrome.
    Carvalho JF; Shoenfeld Y
    Lupus; 2021 Nov; 30(13):2176-2178. PubMed ID: 34569385
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiphospholipid antibodies and thrombosis.
    Musiał J
    Thromb Res; 2012 Mar; 129(3):345-7. PubMed ID: 22119156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
    Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
    Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical relevance of antiphospholipid antibodies in rheumatology].
    Gromnica-Ihle E; Franz J
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):525-9. PubMed ID: 7856256
    [No Abstract]   [Full Text] [Related]  

  • 7. Cut-off levels based on deviation from standard negative control is better than moderate level based on fixed cut-off for ACA assessed using ELISA for the diagnosis of antiphospholipid syndrome.
    Effendy S; Tambunan KL; Reksodiputro AH
    Acta Med Indones; 2005; 37(1):12-9. PubMed ID: 15879633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The manifestations of IHD and the status of the coronary arteries in patients with the antiphospholipid syndrome].
    Karpov IuA; Nasonov EL; Vil'chinskaia MIu; Fomicheva OA; Tvorogova MG; Alekberova ZS; Aleksandrova EN; Pavlov NA; Sergakova LM; Samoĭlemko LE
    Ter Arkh; 1995; 67(10):27-31. PubMed ID: 8779098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary antiphospholipid syndrome: clinical experience of 6 patients].
    Gutiérrez M; Figueroa F; Massardo L; Alfaro J; Ferreira E; Jacobelli S
    Rev Med Chil; 1991 Sep; 119(9):1001-7. PubMed ID: 1845092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-beta(2)-glycoprotein I ELISA assay: the influence of different antigen preparations.
    Cavazzana A; Pengo V; Tonello M; Noventa F; Grossi C; Borghi MO; de Moerloose P; Reber G; Ruffatti A
    Thromb Haemost; 2009 Apr; 101(4):789-91. PubMed ID: 19350132
    [No Abstract]   [Full Text] [Related]  

  • 11. More on: criteria to define the antiphospholipid syndrome.
    Tripodi A
    J Thromb Haemost; 2008 Jun; 6(6):1049-50. PubMed ID: 18363821
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiphospholipid antibodies, lupus anticoagulant and thrombosis].
    Capel P
    Rev Med Brux; 1997 Jun; 18(3):108-10. PubMed ID: 9273597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiphospholipid antibodies and antiphospholipid syndrome: diagnosis and management].
    García-García C
    Actas Dermosifiliogr; 2007; 98(1):16-23. PubMed ID: 17374329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invitation to a debate on the serological criteria that define the antiphospholipid syndrome.
    Galli M; Reber G; de Moerloose P; de Groot PG
    J Thromb Haemost; 2008 Feb; 6(2):399-401. PubMed ID: 18067604
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of thromboembolism in patients with idiopathic autoimmune hemolytic disease and antiphospholipid antibodies: results from a prospective, case-control study.
    Bongarzoni V; Annino L; Roveda A; Amendolea MA; Tirindelli MC; Avvisati G
    Haematologica; 2005 May; 90(5):711-3. PubMed ID: 15929203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome.
    Atsumi T; Khamashta MA; Andujar C; Leandro MJ; Amengual O; Ames PR; Hughes GR
    J Rheumatol; 1998 Jan; 25(1):69-73. PubMed ID: 9458205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is antiphospholipid antibody determination clinically relevant to the vasculitides?
    Cuchacovich R; Espinoza LR
    Semin Arthritis Rheum; 2001 Aug; 31(1):1-3. PubMed ID: 11503133
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies and the antiphospholipid syndrome II: limitations, standardization, and clinical utility of laboratory testing.
    Favaloro EJ; Wong RC
    Semin Thromb Hemost; 2008 Jun; 34(4):309-12. PubMed ID: 18814063
    [No Abstract]   [Full Text] [Related]  

  • 20. The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome.
    Chen DY; Tzang BS; Chen YM; Lan JL; Tsai CC; Hsu TC
    Clin Chim Acta; 2010 Aug; 411(15-16):1084-9. PubMed ID: 20385113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.